Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Atrial Fibrillation After TAVR.
Kawashima H, Watanabe Y, Hioki H, Kozuma K, Kataoka A, Nakashima M, Nagura F, Nara Y, Yashima F, Tada N, Naganuma T, Yamawaki M, Yamanaka F, Shirai S, Mizutani K, Tabata M, Ueno H, Takagi K, Yamamoto M, Hayashida K; OCEAN-TAVI Investigator.
Kawashima H, et al. Among authors: yamawaki m.
JACC Cardiovasc Interv. 2020 Nov 23;13(22):2587-2597. doi: 10.1016/j.jcin.2020.09.013. Epub 2020 Oct 28.
JACC Cardiovasc Interv. 2020.
PMID: 33129818
Free article.